Herantis Pharma will participate at Sachs 23rd Annual Biotech Forum and ØU Life Science Investor Conference in September 2023

Herantis Pharma Plc | Press Release | September 04, 2023 at 17:10:00 EEST

Herantis Pharma Plc, Press Release, 4 September 2023 at 17:10 EEST

Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Herantis will participate in the following conferences in September 2023:

Sachs 23rd Annual Biotech in Europe Forum
Dates: September 20th – 21st, 2023
Location: Basel, Switzerland
1:1 meetings and company presentation.

CEO, Antti Vuolanto will participate in a panel discussion at Sachs, September 20th, 17:10 CEST.

Topic: Advances in Approaches to Neurological Disorders

Co-Chaired by:

Jenny Laird, VP, Search & Evaluation Neuroscience, Eli Lilly and Company

Henrik Sindal Jensen, Senior Director, Corporate Business Development & Strategy, H. Lundbeck A/S

ØU Life Science Investor Conference
Dates: September 27th, 2023
Location: Copenhagen, Denmark
CEO, Antti Vuolanto will give a company presentation at 14:05-14:35 CEST.

If you want a 1:1 meeting with Herantis, you can connect with us directly at ir@herantis.com.